Private Capital Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,419
| Closed | -$133K | – | 110 |
|
|
2021
Q1 | $133K | Sell |
12,419
-12,420
| -50% | -$133K | 0.02% | 97 |
|
|
2020
Q4 | $365K | Buy |
+24,839
| New | +$365K | 0.07% | 71 |
|
|
2016
Q4 | – | Sell |
-146,633
| Closed | -$2.17M | – | 122 |
|
|
2016
Q3 | $2.17M | Buy |
+146,633
| New | +$2.17M | 0.77% | 41 |
|
|
2016
Q2 | – | Sell |
-25,000
| Closed | -$231K | – | 114 |
|
|
2016
Q1 | $231K | Sell |
25,000
-451,069
| -95% | -$4.17M | 0.1% | 101 |
|
|
2015
Q4 | $6M | Sell |
476,069
-2,500
| -0.5% | -$31.5K | 2.59% | 8 |
|
|
2015
Q3 | $6.17M | Sell |
478,569
-25,993
| -5% | -$335K | 2.58% | 5 |
|
|
2015
Q2 | $11M | Buy |
504,562
+420,742
| +502% | +$9.18M | 3.59% | 1 |
|
|
2015
Q1 | $1.7M | Buy |
+83,820
| New | +$1.7M | 0.62% | 52 |
|